These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26572611)

  • 1. Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor.
    Kellici TF; Ntountaniotis D; Kritsi E; Zervou M; Zoumpoulakis P; Potamitis C; Durdagi S; Salmas RE; Ergun G; Gokdemir E; Halabalaki M; Gerothanassis IP; Liapakis G; Tzakos A; Mavromoustakos T
    Curr Med Chem; 2016; 23(1):36-59. PubMed ID: 26572611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II Type 1 Receptor Homology Models: A Comparison Between In Silico and the Crystal Structures.
    Kellici TF
    Methods Mol Biol; 2018; 1824():449-460. PubMed ID: 30039424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.
    Singh KD; Unal H; Desnoyer R; Karnik SS
    J Chem Inf Model; 2018 Jan; 58(1):182-193. PubMed ID: 29195045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Rational Drug Design for Hypertension through NMR Spectroscopy.
    Chontzopoulou E; Tzakos AG; Mavromoustakos T
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.
    Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X
    Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans and Cis Conformations of the Antihypertensive Drug Valsartan Respectively Lock the Inactive and Active-like States of Angiotensin II Type 1 Receptor: A Molecular Dynamics Study.
    Wang L; Yan F
    J Chem Inf Model; 2018 Oct; 58(10):2123-2130. PubMed ID: 30212210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.
    Zhang J; Liu X; Wang SQ; Liu GY; Xu WR; Cheng XC; Wang RL
    J Biomol Struct Dyn; 2017 Sep; 35(12):2665-2680. PubMed ID: 27602589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding determinants for angiotensin II type 1 receptor from computer simulations.
    Matsoukas MT; Cordomí A; Ríos S; Pardo L; Tselios T
    J Chem Inf Model; 2013 Nov; 53(11):2874-83. PubMed ID: 24090110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into AT1 receptor activation through AngII binding studies.
    Matsoukas MT; Potamitis C; Plotas P; Androutsou ME; Agelis G; Matsoukas J; Zoumpoulakis P
    J Chem Inf Model; 2013 Nov; 53(11):2798-811. PubMed ID: 24053563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
    Sallander J; Wallinder C; Hallberg A; Åqvist J; Gutiérrez-de-Terán H
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1355-9. PubMed ID: 26810314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
    Takezako T; Unal H; Karnik SS; Node K
    Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the Angiotensin receptor revealed by serial femtosecond crystallography.
    Zhang H; Unal H; Gati C; Han GW; Liu W; Zatsepin NA; James D; Wang D; Nelson G; Weierstall U; Sawaya MR; Xu Q; Messerschmidt M; Williams GJ; Boutet S; Yefanov OM; White TA; Wang C; Ishchenko A; Tirupula KC; Desnoyer R; Coe J; Conrad CE; Fromme P; Stevens RC; Katritch V; Karnik SS; Cherezov V
    Cell; 2015 May; 161(4):833-44. PubMed ID: 25913193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.
    Takezako T; Unal H; Karnik SS; Node K
    Mol Pharmacol; 2015 Sep; 88(3):488-501. PubMed ID: 26121982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II cyclic analogs as tools to investigate AT
    St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
    Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1/adenosine A
    Oliveira PA; Dalton JAR; López-Cano M; Ricarte A; Morató X; Matheus FC; Cunha AS; Müller CE; Takahashi RN; Fernández-Dueñas V; Giraldo J; Prediger RD; Ciruela F
    Sci Rep; 2017 May; 7(1):1857. PubMed ID: 28500295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors.
    Kellici TF; Tzakos AG; Mavromoustakos T
    Molecules; 2015 Mar; 20(3):3868-97. PubMed ID: 25738535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design and Synthesis of AT1R Antagonists.
    Georgiou N; Gkalpinos VK; Katsakos SD; Vassiliou S; Tzakos AG; Mavromoustakos T
    Molecules; 2021 May; 26(10):. PubMed ID: 34069122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.